| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 116,015 | 110,157 | 209,680 | 131,011 | | Cost of Revenue |
-
|
-
|
-
| (267,176) | | | Gross Profit | 116,015 | 110,157 | 209,680 | 398,187 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 95,053 | 102,329 | 118,095 | 369,508 | | Non Recurring | 20,000 |
-
| 1,704 | 29,164 | | Others | 182,835 | 173,328 | 119,405 | 40,161 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (181,873) | (165,500) | (29,524) | (40,646) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (191,888) | (165,500) | (25,908) | (42,117) | | Interest Expense | 10,018 | 10,192 | 10,783 | 10,140 | | Income Before Tax | (201,906) | (175,692) | (36,691) | (52,257) | | Income Tax Expense | (60,004) | (60,586) | (9,813) | (19,728) | | Minority Interest |
-
|
-
| 3,616 | 30 | | | | Net Income From Continuing Ops | (141,902) | (115,106) | (26,878) | (31,028) | | | Non-recurring Events | | Discontinued Operations | (4,289) |
-
|
-
| (1,224) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (146,191) | (115,106) | (26,878) | (32,252) | | Preferred Stock And Other Adjustments | 11,847 | 2,589 |
-
|
-
| | | Net Income Applicable To Common Shares | ($134,344) | ($112,517) | ($26,878) | ($32,252) |
|
1.48% Nasdaq 
Income Statement
